‘Take action against errant hospitals’

NEW DELHI : Two days after the National Pharmaceutical Pricing Authority (NPPA) released its report confirming profiteering by four top private hospitals in medicine and consumable cost to patients, the complainants have demanded strong action in the cases.

Gopendra Singh Parmar, father of Sourya Pratap who was treated for dengue at Medanta — the Medicity, Gurgaon, alleged that more than 45% of his son’s bill of Rs 15.8 lakh was for medicines and consumables.

“The charges were highly inflated. I have complained to everyone, from the local CMO to Haryana government and even the PMO. But no concrete action has been taken against the hospital,” he said. Pramar threatened to take his life if he didn’t get justice.

Jayant Singh, whose daughter Adya Singh was admitted to Fortis hospital, Gurgaon and charged in excess of Rs 16 lakh, said he has filed a writ petition in the Supreme Court demanding strict regulation and audit of corporate hospitals to weed out unethical practices. K M Gopakumar, from All India Drug Action Network, said that the government should act decisively to put an end to pushing peoples’ health over the edge. tnn

  • Related Posts

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    Six fake doctors arrested in Hyderabad

    Six fake doctors arrested in Hyderabad